Aligarh Muslim University
MUAZZAM HASAN
Postpartum hemorrhage continues to be the leading cause of maternal morbidity and mortality. Globally, it is responsible for 25% of all pregnancy-related deaths. PPH is unpredictable and may occur in the absence of risk factors. Tranexamic acid is an antifibrinolytic proven to reduce blood loss and transfusion requirements for various surgeries. This study aims to explore the effectiveness of tranexamic acid as an adjunct to other uterotonics before the Caesarian Section.
Post Partum Hemorrhage
Tranexamic acid injection
Placebo
NA
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 300 participants |
| Masking : | DOUBLE |
| Primary Purpose : | PREVENTION |
| Official Title : | Prophylactic Role Of Tranexamic Acid To Reduce Blood Loss During Caesarean Delivery : A Prospective Study. |
| Actual Study Start Date : | 2024-10-01 |
| Estimated Primary Completion Date : | 2025-03-30 |
| Estimated Study Completion Date : | 2025-03-30 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years to 45 Years |
| Sexes Eligible for Study: | FEMALE |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
ASJSATDS Medical College
Fatehpur, Uttar Pradesh, India, 212601